[HTML][HTML] Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

X Xie, T Yu, X Li, N Zhang, LJ Foster, C Peng… - Signal transduction and …, 2023 - nature.com
Undruggable proteins are a class of proteins that are often characterized by large, complex
structures or functions that are difficult to interfere with using conventional drug design …

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

RJ Kathawala, P Gupta, CR Ashby Jr, ZS Chen - Drug resistance updates, 2015 - Elsevier
ATP-binding cassette (ABC) transporters represent one of the largest and oldest families of
membrane proteins in all extant phyla from prokaryotes to humans, which couple the energy …

[HTML][HTML] Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

S Wu, L Fu - Molecular cancer, 2018 - Springer
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …

[HTML][HTML] LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1

Z Chang, Y Jia, W Zhang, L Song, M Gao, M Li… - Journal of Experimental …, 2018 - Springer
Background This study aims to clarify the underlying mechanism for the tumor suppressive
function of lnc TUSC7 in chemotherapy resistance of esophageal squamous cell carcinoma …

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2

CP Wu, SH Hsiao, YS Wu - Drug Resistance Updates, 2023 - Elsevier
The overexpression of the human ATP-binding cassette (ABC) transporters in cancer cells is
a common mechanism involved in developing multidrug resistance (MDR). Unfortunately …

[HTML][HTML] Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance

N Anreddy, P Gupta, RJ Kathawala, A Patel… - Molecules, 2014 - mdpi.com
Tyrosine kinases (TKs) play an important role in pathways that regulate cancer cell
proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been …

Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters

ZX He, TQ Zhao, YP Gong, X Zhang, LY Ma… - European Journal of …, 2020 - Elsevier
The multidrug resistance (MDR) phenomenon in cancer cells is the major obstacle leading
to failure of chemotherapy accompanied by the feature of intractable and recurrence of …

ABCG2/BCRP: specific and nonspecific modulators

D Peña‐Solórzano, SA Stark, B König… - Medicinal research …, 2017 - Wiley Online Library
Multidrug resistance (MDR) in cancer cells is the development of resistance to a variety of
structurally and functionally nonrelated anticancer drugs. This phenomenon has become a …

[HTML][HTML] Voruciclib, a potent CDK4/6 inhibitor, antagonizes ABCB1 and ABCG2-mediated multi-drug resistance in cancer cells

P Gupta, YK Zhang, XY Zhang, YJ Wang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: The overexpression of ATP-Binding Cassette (ABC) transporters has
known to be one of the major obstacles impeding the success of chemotherapy in drug …

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo

AA De Vera, P Gupta, Z Lei, D Liao, S Narayanan… - Cancer letters, 2019 - Elsevier
Phosphoinositide 3-kinase gamma isoform (PI3Kγ) plays a critical role in myeloid-derived
cells of the immunosuppressive tumor microenvironment. IPI-549, a recently discovered …